Genome-wide parsing based on sequence cluster profiles showed that approximately 2 to 5% of all ORFs in nonviral genomes belong to the NAD(P)-utilizing enzyme family. The two-domain Rossmann fold and short-chain oxidoreductases account for 73 to 95% of all NAD(P)-utilizing enzymes. Fig. 1 , a correlation can be made between sequence, structure, and NAD(P)-pharmacophore. The information gained can be used for a chemogenomics approach that leverages sequence information to reduce the effort required to identify ligands. In the case of NAD(P)-utilizing enzymes, it is likely to have a significant impact in the identification of novel anti-infective targets, among other possible areas.
DISCUSSION. As shown in

